Sanjay Kumar Singh, Karthik Jerome, Business Standard

Stories by Sanjay Kumar Singh, Karthik Jerome, Business Standard

Study Abroad: How To Deal With Rising Costs

Study Abroad: How To Deal With Rising Costs

Rediff.com   29 Jul 2022

The rupee depreciation will work in favour of students who are currently studying in the US and plan to secure a job that pays in dollars.

Inflation: Maintain 10-15% Investment In Gold

Inflation: Maintain 10-15% Investment In Gold

Rediff.com   15 Jul 2022

Despite its recent underperformance, gold must be a part of your portfolio.

Avoid sector, thematic funds; stick to diversified equity offerings

Avoid sector, thematic funds; stick to diversified equity offerings

Rediff.com   8 Jul 2022

Many retail investors, who are experiencing their first bear market, are shocked at the erosion in the value of their mutual fund (MF) portfolios. The pain is especially acute for those who had taken excessive exposure to sector/thematic and small-cap funds. Even international diversification has failed to stanch the bleed in this downturn.

Need Cash? Opt For Loan Against Securities

Need Cash? Opt For Loan Against Securities

Rediff.com   22 Jun 2022

If you pledge market-linked instruments and their value plummets, you will have to provide additional collateral, points out Sanjay Kumar Singh.

Planning To Buy Critical Illness Plan? Read this

Planning To Buy Critical Illness Plan? Read this

Rediff.com   7 Jun 2022

'A policy that covers a wider range of diseases will offer greater peace of mind.'

Weakening Rupee? How To Neutralise Impact

Weakening Rupee? How To Neutralise Impact

Rediff.com   17 May 2022

Having exposure to international funds and gold is a must for those who have foreign currency-denominated goals.

Covid cases are being detected by accident

Covid cases are being detected by accident

Rediff.com   30 Apr 2022

'A patient visits for any other treatment, but a routine Covid test finds him to be positive.' 'Not only are they, but their whole family is also coming out to be positive.'

Gold loan: Low-cost option and credit score no bar

Gold loan: Low-cost option and credit score no bar

Rediff.com   22 Apr 2022

Gold loan is currently the fastest-growing loan category (among the various types disbursed to individuals). On February 26, 2021, the outstanding loan against gold jewellery stood at Rs 56,596 crore. By February 25, 2022, it had risen to Rs 71,408 crore, a year-on-year growth of 26.2 per cent, according to the Reserve Bank of India's (RBI's) data. Several factors are driving the demand for gold loans.

New ITR form makes it easier to report foreign assets

New ITR form makes it easier to report foreign assets

Rediff.com   2 Apr 2022

As these forms are quite elaborate, their early notification will give assessees more time to get the documentation and paperwork ready, and hence make complete disclosures while filing their returns.

'Paytm's business will continue'

'Paytm's business will continue'

Rediff.com   23 Mar 2022

'We now understand things that we have to correct.'

Ukraine War: Invest In Multi-Asset Funds

Ukraine War: Invest In Multi-Asset Funds

Rediff.com   14 Mar 2022

Multi-asset funds offer exposure to gold, which tends to do well in times of geopolitical tensions and inflationary pressures, suggests Sanjay Kumar Singh.

'Wise to invest in quality large-cap and mid-cap stocks'

'Wise to invest in quality large-cap and mid-cap stocks'

Rediff.com   7 Mar 2022

'Earning expectations remain strong.'

80D Limit Available? Opt For Health Check-up

80D Limit Available? Opt For Health Check-up

Rediff.com   4 Mar 2022

You can avail of tax deduction on expenses incurred on preventive health check-ups. This provision is beneficial to younger people who don't exhaust their Section 80D limit with their health insurance premium.

Planning to Invest in Silver? Read This

Planning to Invest in Silver? Read This

Rediff.com   22 Jan 2022

Treat silver as part of the procyclical or growth assets in your portfolio, advises Sanjay Kumar Singh.

Want Health Insurance? Read This

Want Health Insurance? Read This

Rediff.com   8 Jan 2022

Make sure that the waiting period on pre-existing diseases does not exceed two years. Avoid policies that come with room rent and ICU capping, suggests Sanjay Kumar Singh.

Don't Be OVER-OBSESSED With Stocks

Don't Be OVER-OBSESSED With Stocks

Rediff.com   3 Jan 2022

Exposure to debt funds and gold is essential even if current returns from these asset classes are low, suggests Sanjay Kumar Singh.

Covaxin safe for children: Bharat Biotech

Covaxin safe for children: Bharat Biotech

Rediff.com   31 Dec 2021

Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

Rediff.com   28 Dec 2021

'Antibodies remain in the blood for at least seven to nine months.'

Why did Paytm stock drop by 8%?

Why did Paytm stock drop by 8%?

Rediff.com   16 Dec 2021

After dropping to a low of Rs 1,298 apiece, the stock finished at Rs 1,380, its lowest level since November 22, the second day of listing.

Difficult to Make Money in IPOs with Leveraged Bets

Difficult to Make Money in IPOs with Leveraged Bets

Rediff.com   4 Dec 2021

HNI investors need an optimal mix of oversubscription and listing-day gain to make money on leveraged bets, notes Sanjay Kumar Singh.